Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00768924 · ClinicalTrials.gov registry record

CopiOs(TM) Bone Void Filler in the Post-Harvest Iliac Crest

A clinical trial, sponsored by Zimmer Biomet.

Completed
Registry status
35
Enrollment target

NCT00768924 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00768924 has completed, sponsored by Zimmer Biomet.

COMPLETED
Registry status
35 participants
Enrollment target

Study Summary

The CopiOs Bone Void Filler (BVF) is a synthetic bone graft material consisting of calcium phosphate dehydrate within lyophilized type I bovine collagen that has been formed into pads of various sizes for surgical implantation. Pre-clinical animal studies suggest that the bone healing strength of CopiOs to be equivalent to autograft.

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2007-03
Est. Completion 2008-12

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT00768924

The ClinicalTrials.gov registry entry for NCT00768924 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00768924 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00768924 about?

NCT00768924 is a clinical study titled "CopiOs(TM) Bone Void Filler in the Post-Harvest Iliac Crest". The CopiOs Bone Void Filler (BVF) is a synthetic bone graft material consisting of calcium phosphate dehydrate within lyophilized type I bovine collagen that has been formed into pads of various sizes for surgical implantation. Pre-clinical animal studies suggest that the bone healing strength of Co...

What is the current status of trial NCT00768924?

This trial is currently completed. The enrollment target is 35 participants. The study started on 2007-03. Estimated completion is 2008-12.

Who is sponsoring clinical trial NCT00768924?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.